sun pharma to buy organon in $11.75 billion deal
Mumbai, April 28 -- Sun Pharmaceutical Industries on Monday announced the $11.75 billion purchase of US drugmaker Organon & Co. The acquisition ranks as the second-largest outbound deal by an Indian company, behind Tata Steel's 2007 deal to buy British steel maker Corus Group for $12 billion.P14...
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.